JP2010523571A5 - - Google Patents

Download PDF

Info

Publication number
JP2010523571A5
JP2010523571A5 JP2010502149A JP2010502149A JP2010523571A5 JP 2010523571 A5 JP2010523571 A5 JP 2010523571A5 JP 2010502149 A JP2010502149 A JP 2010502149A JP 2010502149 A JP2010502149 A JP 2010502149A JP 2010523571 A5 JP2010523571 A5 JP 2010523571A5
Authority
JP
Japan
Prior art keywords
composition
item
tris
lyophilizate
crystalline compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010502149A
Other languages
English (en)
Japanese (ja)
Other versions
JP5659010B2 (ja
JP2010523571A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/004449 external-priority patent/WO2008124097A2/en
Publication of JP2010523571A publication Critical patent/JP2010523571A/ja
Publication of JP2010523571A5 publication Critical patent/JP2010523571A5/ja
Application granted granted Critical
Publication of JP5659010B2 publication Critical patent/JP5659010B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010502149A 2007-04-06 2008-04-04 イソホスホルアミドマスタードの塩およびそれらの類似体 Expired - Fee Related JP5659010B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US92214807P 2007-04-06 2007-04-06
US60/922,148 2007-04-06
US92736307P 2007-05-02 2007-05-02
US60/927,363 2007-05-02
US93491407P 2007-06-15 2007-06-15
US60/934,914 2007-06-15
US123707P 2007-10-30 2007-10-30
US61/001,237 2007-10-30
PCT/US2008/004449 WO2008124097A2 (en) 2007-04-06 2008-04-04 Salts of isophosphoramide mustard and analogs thereof

Publications (3)

Publication Number Publication Date
JP2010523571A JP2010523571A (ja) 2010-07-15
JP2010523571A5 true JP2010523571A5 (cg-RX-API-DMAC7.html) 2012-05-31
JP5659010B2 JP5659010B2 (ja) 2015-01-28

Family

ID=39387443

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010502149A Expired - Fee Related JP5659010B2 (ja) 2007-04-06 2008-04-04 イソホスホルアミドマスタードの塩およびそれらの類似体

Country Status (22)

Country Link
US (2) US8604007B2 (cg-RX-API-DMAC7.html)
EP (2) EP2155682B1 (cg-RX-API-DMAC7.html)
JP (1) JP5659010B2 (cg-RX-API-DMAC7.html)
KR (3) KR20150139620A (cg-RX-API-DMAC7.html)
CN (2) CN102942589B (cg-RX-API-DMAC7.html)
AU (1) AU2008236684B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0809999A2 (cg-RX-API-DMAC7.html)
CA (1) CA2684747A1 (cg-RX-API-DMAC7.html)
CY (1) CY1116596T1 (cg-RX-API-DMAC7.html)
DK (2) DK2155682T3 (cg-RX-API-DMAC7.html)
ES (1) ES2547302T3 (cg-RX-API-DMAC7.html)
HU (1) HUE025949T2 (cg-RX-API-DMAC7.html)
IL (2) IL201424A (cg-RX-API-DMAC7.html)
MX (1) MX2009010820A (cg-RX-API-DMAC7.html)
NZ (1) NZ580341A (cg-RX-API-DMAC7.html)
PL (1) PL2155682T3 (cg-RX-API-DMAC7.html)
PT (2) PT2581367E (cg-RX-API-DMAC7.html)
RU (1) RU2527531C2 (cg-RX-API-DMAC7.html)
SI (1) SI2155682T1 (cg-RX-API-DMAC7.html)
TW (2) TWI490226B (cg-RX-API-DMAC7.html)
WO (1) WO2008124097A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200907722B (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2585125C (en) * 2004-10-25 2014-04-22 Lee Morgan Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
US7964583B2 (en) * 2006-02-17 2011-06-21 Ziopharm Oncology, Inc. Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
KR20150139620A (ko) 2007-04-06 2015-12-11 지오팜 온콜로지 인코포레이티드 이소포스포르아미드 머스타드의 염 및 이의 동족체
SG183657A1 (en) 2008-07-31 2012-09-27 Ziopharm Oncology Inc Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof
WO2010099213A1 (en) * 2009-02-24 2010-09-02 Dekk-Tec, Inc. Complexes of 4-hydroperoxy ifosfamide as anti-tumor agents
US20130196000A1 (en) * 2012-01-31 2013-08-01 Ziopharm Oncology, Inc. Combination therapy including isophosphoramide mustard, analogs, or salts thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU427945A1 (ru) 1972-07-24 1974-05-15 Институт элементоорганических соединений СПОСОБ ПОЛУЧЕНИЯа ПОЛИФТОРАЛКИЛЗАМЕЩЕННЫХБЕНЗИЛДИХЛОРФОСФАТОВ
JPS5159886A (cg-RX-API-DMAC7.html) 1974-11-20 1976-05-25 Shionogi Seiyaku Kk
US4537883A (en) * 1982-11-12 1985-08-27 Mead Johnson & Company Lyophilized cyclophosphamide
US5091552A (en) 1986-06-30 1992-02-25 Board Of Regents, The University Of Texas System Novel antitumor aldophosphamide analogs
US5055459A (en) * 1986-06-30 1991-10-08 Board Of Regents, The University Of Texas Selective elimination of malignant cells from bone marrow by bis (acyloxy) propylphosphoramidates
US5204335A (en) * 1986-10-31 1993-04-20 Asta Pharma Aktiengesellschaft Ifosfamide lyophilisate and process for its preparation
WO1993021173A1 (en) 1992-04-17 1993-10-28 Abbott Laboratories Taxol derivatives
US5468499A (en) * 1993-11-15 1995-11-21 Ohio State University Liposomes containing the salt of phosphoramide mustard and related compounds
US5659061A (en) * 1995-04-20 1997-08-19 Drug Innovation & Design, Inc. Tumor protease activated prodrugs of phosphoramide mustard analogs with toxification and detoxification functionalities
DK0795334T3 (da) * 1996-03-12 2006-06-06 Sanofi Aventis Deutschland Nye prodrugs til behandling af tumorer og betændelsessygdomme
US5912264A (en) 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
JP4629238B2 (ja) * 1999-05-24 2011-02-09 サザン・リサーチ・インスティテュート イソホスホアミドマスタード・アナログ及びその使用
CO5280224A1 (es) 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
AU2001248201B2 (en) 2000-04-13 2006-12-14 Hsc Research And Development Limited Partnership Compounds for modulating cell proliferation
ATE350383T1 (de) 2002-08-23 2007-01-15 Sloan Kettering Inst Cancer Synthese von epothilonen, zwischenprodukte dafür, analoga und deren verwendungen
CA2585125C (en) * 2004-10-25 2014-04-22 Lee Morgan Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
KR20150139620A (ko) 2007-04-06 2015-12-11 지오팜 온콜로지 인코포레이티드 이소포스포르아미드 머스타드의 염 및 이의 동족체

Similar Documents

Publication Publication Date Title
JP2018535229A (ja) 置換トリアゾロピペラジン類parp抑制剤及びその製造方法並びに用途
CN105130959B (zh) 嘧啶衍生物pim激酶抑制剂及其制备方法与在制药中的应用
CN105218523A (zh) 吡啶衍生物pim激酶抑制剂及其制备方法与在制药中的应用
JP2017519004A (ja) 白金耐性の克服における使用のためのテキサフィリン−白金(iv)コンジュゲート及び組成物
CN105254624A (zh) 异噻唑衍生物pim激酶抑制剂及其制备方法与在制药中的应用
JP5659010B2 (ja) イソホスホルアミドマスタードの塩およびそれらの類似体
JP2008517949A (ja) 抗腫瘍剤としてのイソホスホルアミドマスタードの塩及びその類似物
CN110845408A (zh) 同位素富集的乐伐替尼
JP5769831B2 (ja) イソホスホルアミドマスタードおよびその類似体の合成および製剤
JP2010511041A5 (cg-RX-API-DMAC7.html)
CN112638922B (zh) 金(iii)配合物、其缀合物、包含其的药物组合物以及用途和制备其的方法
US11008293B2 (en) 5-carboxamide-2-thiobarbituric acids and use thereof as medicaments
CN101790530A (zh) 抗肿瘤治疗用双咔唑类dna嵌入剂
WO2025083561A1 (en) Novel lead small molecule inhibitors on undruggable target towards anticancer activity
CN119874605A (zh) 苯甲酰基哌啶基哌啶衍生物及其制备方法与应用
WO2025083564A1 (en) Novel small molecule degrader as a potential anticancer
US20250059194A1 (en) Ulk1 and ulk2 inhibitors
WO2025083570A1 (en) Novel small-molecule agents in overcoming tumor regression in cancers
CN103570689B (zh) 用于抗肿瘤药物的对硝基芳甲基克里唑替尼缺氧激活前药
WO2022192341A1 (en) Quinoxaline urea inhibitors of ikk-beta and nf-kb
JP2012518659A5 (cg-RX-API-DMAC7.html)